NLRC5/CITA: A Key Player in Cancer Immune Surveillance.
NLRC5/CITA: A Key Player in Cancer Immune Surveillance.
复制标题
DOI:
10.1016/j.trecan.2016.12.003
复制
发表时间:
2017-01
期刊:
影响因子:
18.4
通讯作者:
Kobayashi KS
中科院分区:
文献类型:
--
作者:
Yoshihama S;Vijayan S;Sidiq T;Kobayashi KS
Cancer cells need to escape immune surveillance for successful tumor growth. Loss of MHC class I has been described as a major immune evasion strategy in many cancers. MHC class I transactivator (CITA), NLRC5, has found to be a key transcription coactivator of MHC class I genes. Recent genetic studies revealed that NLRC5 is a major target for cancer immune evasion mechanism. The reduced expression or activity of NLRC5 caused by promoter methylation, copy number loss, or somatic mutations is associated with defective MHC class I expression, impaired cytotoxic T cell activation and poor patient prognosis. Here we review the role of NLRC5 in cancer immune evasion and the future prospects for cancer research.
登录
查看更多内容
DOI:
10.1056/nejmoa1003466
发表时间:
2010-08-19
期刊:
The New England journal of medicine
影响因子:
--
作者:
Hodi FS;O'Day SJ;McDermott DF;Weber RW;Sosman JA;Haanen JB;Gonzalez R;Robert C;Schadendorf D;Hassel JC;Akerley W;van den Eertwegh AJ;Lutzky J;Lorigan P;Vaubel JM;Linette GP;Hogg D;Ottensmeier CH;Lebbé C;Peschel C;Quirt I;Clark JI;Wolchok JD;Weber JS;Tian J;Yellin MJ;Nichol GM;Hoos A;Urba WJ
通讯作者:
Urba WJ
DOI:
10.4049/jimmunol.1200064
发表时间:
2012-07-15
期刊:
Journal of immunology (Baltimore, Md. : 1950)
影响因子:
--
作者:
Biswas A;Meissner TB;Kawai T;Kobayashi KS
通讯作者:
Kobayashi KS
影响因子:
4.4
作者:
Benko, Szilvia;Magalhaes, Joao G.;Girardin, Stephen E.
通讯作者:
Girardin, Stephen E.
影响因子:
7.2
作者:
Inoue M;Mimura K;Izawa S;Shiraishi K;Inoue A;Shiba S;Watanabe M;Maruyama T;Kawaguchi Y;Inoue S;Kawasaki T;Choudhury A;Katoh R;Fujii H;Kiessling R;Kono K
通讯作者:
Kono K
影响因子:
32.4
作者:
Gobin, SJP;Peijnenburg, A;vandenElsen, PJ
通讯作者:
vandenElsen, PJ